Targeting MDM2 for Neuroblastoma Therapy: In Vitro and In Vivo Anticancer Activity and Mechanism of Action
Wei Wang(Capital Medical University), Ruiwen Zhang(Center for Excellence in Molecular Cell Science), Jianhua Yang(Children's National), John K. Buolamwini(University of Tennessee Health Science Center), Jennifer H. Foster(Children's Cancer Center), Mehrdad Rajaei(University of Houston), Atif Zafar(St. Michael's Hospital), Xinjie Wang(First Affiliated Hospital of Henan University of Traditional Chinese Medicine), Hemantkumar Deokar(Rosalind Franklin University of Medicine and Science), Ji Youn Youn(University of California, Los Angeles), Jia Zhou(Io Therapeutics (United States))
Cited by 15
Related Papers
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
|Protein & Cell|2013|767
Molecular Cloning, Characterization, and Expression in Escherichia coli of Full-length cDNAs of Three Human Glutathione S-Transferase Pi Gene Variants
|Journal of Biological Chemistry|1997|722
Molecular targeting therapies for neuroblastoma: Progress and challenges
|Medicinal Research Reviews|2020|385
Recent update on basic mechanisms of spinal cord injury
|Neurosurgical Review|2018|344
A Strategy for Modulation of Enzymes in the Ubiquitin System
|Science|2013|296